Skip to Main Content

Author Details

Joanne N Engel
University of California san francisco
1977
92
49
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36795017Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis.EMBO J2023
37712060In host evolution of beta lactam resistance during active treatment for <i>Pseudomonas aeruginosa</i> bacteremia.Front Cell Infect Microbiol2023
34301869Mechanotaxis directs <i>Pseudomonas aeruginosa</i> twitching motility.Proc Natl Acad Sci U S A2021
33875435Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria.Antimicrob Agents Chemother2021
29703496Emerging Role of Retromer in Modulating Pathogen Growth.Trends Microbiol2018
30314703Both the N- and C- terminal regions of the Chlamydial inclusion protein D (IncD) are required for interaction with the pleckstrin homology domain of the ceramide transport protein CERT.Biochem Biophys Res Commun2018
27881661Par3 integrates Tiam1 and phosphatidylinositol 3-kinase signaling to change apical membrane identity.Mol Biol Cell2017
28166267Bacterial internalization is required to trigger NIK-dependent NF-κB activation in response to the bacterial type three secretion system.PLoS One2017
28252385<i>Chlamydia</i> interfere with an interaction between the mannose-6-phosphate receptor and sorting nexins to counteract host restriction.Elife2017
28193722Targeting the Mucosal Barrier: How Pathogens Modulate the Cellular Polarity Network.Cold Spring Harb Perspect Biol2017
28961810Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.J Antimicrob Chemother2017
27108705Chlamydia cell biology and pathogenesis.Nat Rev Microbiol2016
27145134A scaffold protein connects type IV pili with the Chp chemosensory system to mediate activation of virulence signaling in Pseudomonas aeruginosa.Mol Microbiol2016
26118995Global Mapping of the Inc-Human Interactome Reveals that Retromer Restricts Chlamydia Infection.Cell Host Microbe2015
26041805Type IV pili mechanochemically regulate virulence factors in Pseudomonas aeruginosa.Proc Natl Acad Sci U S A2015
24818947Assessing Pseudomonas virulence using host cells.Methods Mol Biol2014
25375398The Pseudomonas aeruginosa type III translocon is required for biofilm formation at the epithelial barrier.PLoS Pathog2014
24832456Host cell polarity proteins participate in innate immunity to Pseudomonas aeruginosa infection.Cell Host Microbe2014
23480519Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.Cell Microbiol2013
24310120Cystic fibrosis epithelial cell and bacterial binding.Am J Physiol Lung Cell Mol Physiol2013
23637308Chlamydial intracellular survival strategies.Cold Spring Harb Perspect Med2013
23792737Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia.Am J Physiol Lung Cell Mol Physiol2013
22665491The second type VI secretion system of Pseudomonas aeruginosa strain PAO1 is regulated by quorum sensing and Fur and modulates internalization in epithelial cells.J Biol Chem2012
22452394Lipid acquisition by intracellular Chlamydiae.Cell Microbiol2012
22496644Pseudomonas aeruginosa pili and flagella mediate distinct binding and signaling events at the apical and basolateral surface of airway epithelium.PLoS Pathog2012
21264306FimL regulates cAMP synthesis in Pseudomonas aeruginosa.PLoS One2011
21998584Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection.PLoS Pathog2011
21909260Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development.PLoS Pathog2011
21586644Species-specific interactions of Src family tyrosine kinases regulate Chlamydia intracellular growth and trafficking.mBio2011
21747810Subversion of mucosal barrier polarity by pseudomonas aeruginosa.Front Microbiol2011
21293189Cell migration regulates the kinetics of cytokinesis.Cell Cycle2011
20008072Genetic analysis of the regulation of type IV pilus function by the Chp chemosensory system of Pseudomonas aeruginosa.J Bacteriol2010
20008530Pseudomonas aeruginosa-mediated damage requires distinct receptors at the apical and basolateral surfaces of the polarized epithelium.Infect Immun2010
19168385Role of Pseudomonas aeruginosa type III effectors in disease.Curr Opin Microbiol2009
19801409CbpA: a polarly localized novel cyclic AMP-binding protein in Pseudomonas aeruginosa.J Bacteriol2009
18053004The Pseudomonas aeruginosa type III secreted toxin ExoT is necessary and sufficient to induce apoptosis in epithelial cells.Cell Microbiol2008
18787414Focal adhesion components are essential for mammalian cell cytokinesis.Cell Cycle2008
18485000Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms.Environ Microbiol2008
18369471RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry.PLoS Pathog2008
18369477RNAi screen reveals an Abl kinase-dependent host cell pathway involved in Pseudomonas aeruginosa internalization.PLoS Pathog2008
17235393The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.J Clin Invest2007
17403925Pseudomonas aeruginosa exploits a PIP3-dependent pathway to transform apical into basolateral membrane.J Cell Biol2007
17428306Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacter pylori-induced host cell actin cytoskeletal rearrangements.FEMS Immunol Med Microbiol2007
16921364Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells.Nat Cell Biol2006
17030800Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple steps.Proc Natl Acad Sci U S A2006
15772151The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization.Mol Biol Cell2005
15878208An essential, putative MEK kinase of Leishmania major.Mol Biochem Parasitol2005
15839901Drosophila melanogaster S2 cells: a model system to study Chlamydia interaction with host cells.Cell Microbiol2005
15720546Pseudomonas aeruginosa fimL regulates multiple virulence functions by intersecting with Vfr-modulated pathways.Mol Microbiol2005
14688136The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities.Infect Immun2004
  • 1 - 50 of 92

Recommended Authors

Guillaume Golovkine
University of California berkeley
Career Start Year 2014
Number of shared co-authors 9
Siqi Gong
New Iberia Research Center, University of Louisiana at Lafayette
Career Start Year 2011
Number of shared co-authors 0
Connie Chen
University of California davis
Career Start Year 2009
Number of shared co-authors 0
Seemay Chou
University of California - San Francisco
Career Start Year 2007
Number of shared co-authors 5
George W Liechti
F. Edward Hebert School of Medicine, Uniformed Services University
Career Start Year 2005
Number of shared co-authors 0
Malina A Bakowski
a division of The Scripps Research Institute La Jolla
Career Start Year 2003
Number of shared co-authors 1
Vincent C Tam
Temple University
Career Start Year 2002
Number of shared co-authors 0
Shaeri Mukherjee
G.W. Hooper Foundation, University of California at San Francisco
Career Start Year 2002
Number of shared co-authors 3
Eric D Cambronne
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
Kevin Wang
University of California irvine
Career Start Year 2000
Number of shared co-authors 2
Trevor F Moraes
University of Toronto, University Avenue
Career Start Year 2000
Number of shared co-authors 0
Siddharth Pratap
Meharry Medical College
Career Start Year 1999
Number of shared co-authors 0
Martin Fraunholz
Julius-Maximilians-Universitat Wurzburg
Career Start Year 1998
Number of shared co-authors 1
Jeevan Jyot
University of Florida
Career Start Year 1998
Number of shared co-authors 0
Deborah A Hogan
Geisel School of Medicine at Dartmouth
Career Start Year 1997
Number of shared co-authors 0
Elizabeth R Fischer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 3
Paul de Figueiredo
Texas A&M University, College Station
Career Start Year 1995
Number of shared co-authors 3
Gyorgy Babnigg
Argonne National Laboratory
Career Start Year 1992
Number of shared co-authors 0
George A O'Toole
Geisel School of Medicine at Dartmouth
Career Start Year 1991
Number of shared co-authors 2
Victor Nizet
university of california san diego School of Medicine
Career Start Year 1991
Number of shared co-authors 2
Michele S Swanson
University Of Michigan ann arbor
Career Start Year 1990
Number of shared co-authors 1
Partho Ghosh
University of California
Career Start Year 1986
Number of shared co-authors 1
Barbara J Mann
University of Virginia
Career Start Year 1985
Number of shared co-authors 1
Victor J DiRita
Michigan State University
Career Start Year 1983
Number of shared co-authors 0
Jeff F Miller
and the California NanoSystems Institute, University of California los angeles
Career Start Year 1983
Number of shared co-authors 0
Michael S Gilmore
Harvard Medical School, USA Infectious Disease Institute (P.J.M.B.
Career Start Year 1981
Number of shared co-authors 1
Alan Aderem
Seattle Children's Research Institute
Career Start Year 1979
Number of shared co-authors 2
Thomas F Meyer
Max Planck Institute for Infection Biology
Career Start Year 1979
Number of shared co-authors 6
Robert E W Hancock
University of British Columbia
Career Start Year 1974
Number of shared co-authors 0
Frederick S Southwick
University of Florida College of Medicine
Career Start Year 1969
Number of shared co-authors 0

Collaborators

Cherilyn A Elwell
University of California san francisco
Co-authored papers 14
Yuki F Inclan
University of California san francisco
Co-authored papers 5
Michael A Matthay
Cardiovascular Research Institute, University of California san francisco
Co-authored papers 4
Alexandre Persat
Global Health Institute and Institute for Bioengineering, EPFL
Co-authored papers 4
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 3
John Von Dollen
University of California San Francisco
Co-authored papers 3
Kathleen M Mirrashidi
Genentech Inc.
Co-authored papers 3
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 3
John S Mattick
Australia UNSW RNA Institute
Co-authored papers 3
Zemer Gitai
Princeton University
Co-authored papers 2
Raphael H Valdivia
Duke University
Co-authored papers 2
Jonathan R Pollack
Stanford University School of Medicine
Co-authored papers 2
Suzanne M J Fleiszig
University of California berkeley
Co-authored papers 2
Oren S Rosenberg
University of California san francisco
Co-authored papers 2
Torsten Wittmann
University of California san francisco
Co-authored papers 2
Jessica Sherry
University of California San Francisco
Co-authored papers 2
Andrew J Olive
College of Osteopathic Medicine, Michigan State University
Co-authored papers 1
David A Hume
Mater Research Institute-UQ, Translational Research Institute
Co-authored papers 1
Isabelle Derr??
University of Virginia School of Medicine
Co-authored papers 1
Nadine Czudnochowski
University of California san francisco
Co-authored papers 1
Steve Miller
University of CaliforniaSan Francisco
Co-authored papers 1
Sharon L Reed
university of california san diego Health
Co-authored papers 1
Stefanie J??ger
Institute of Molecular Biosciences, Goethe University Frankfurt
Co-authored papers 1
Erik Verschueren
University of California San Francisco
Co-authored papers 1
Natali Gulbahce
Complete Genomics Inc.
Co-authored papers 1
Masahiro Nishijima
Co-authored papers 1
Anusha M Gopalakrishnan
Duke University
Co-authored papers 1
Bennett H Penn
University of California Davis
Co-authored papers 1
Andrew Frando
Seattle Children's Research Institute
Co-authored papers 1
Rachel Nakagawa
University of California san francisco
Co-authored papers 1
Release 1.2